Asp Isotopes Inc (ASPI) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
Asp Isotopes Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period
Return on Assets, Quarterly Results, Trends, Rankings, Statistics
What is Asp Isotopes Inc 's ROA in the second quarter of 2026?
Asp Isotopes Inc recorded a cumulative net loss of $-117 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -22.35%.
However, within the Basic Materials sector 226 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3846, from total ROA ranking in the first quarter of 2026 at 4767.
ASP Isotopes Inc. Faces Legal Challenges Amid Investor Updates in South AfricaThis week, ASP Isotopes Inc. (NASDAQ: ASPI) welcomed a global group of institutional investors to its facilities in Pretoria, South Africa, for a two-day investor access event. The event was aimed at providing updates on the company s ongoing projects, particularly its Silicon-28, Ytterbium-176, and Carbon-14 facilities. However, the backdrop of this gathering reveals a challenging financial situation for the company.In the fiscal year ending in the third quarter of 2024, ASP Isotopes Inc. reported a staggering cumulative net loss of $27 million. This extensive financial shortfall has resulted in a negative return on assets (ROA) of -51.99%. Such figures raise serious concerns about the company s ability to sustain its operations and execute its growth strategy effectively.
In a recently circulated report, Fuzzy Panda Research, a known short-seller, has cast a spotlight on ASP Isotopes Inc. (NASDAQ: ASPI), an advanced materials company dedicated to the development of isotopes utilized across various industries. The allegations within the report, published on November 26, 2024, have provoked significant investor concern, especially as the company grapples with notable financial challenges. Financial Performance ConcernsASP Isotopes has reported a cumulative net loss of $27 million for the 12 months ending in the third quarter of 2024. This staggering loss has resulted in a negative return on assets (ROA) of -51.99%, raising red flags among analysts and investors regarding the company’s performance and long-term viability. Such financial metrics highlight the company’s difficulties in translating its operational capabilities into sustainable profitability.
In a recent disclosure, ASP Isotopes Inc. (NASDAQ: ASPI) responded to a short seller report released by Fuzzy Panda Research on November 26, 2024, that has raised eyebrows among investors and analysts alike. The company, which operates in the advanced materials sector with a focus on isotope production for various industries, finds itself not only battling short interests but also grappling with significant financial challenges that have been laid bare.Fuzzy Panda, an entity known for its short-selling strategies, is well-positioned to profit from any decline in ASP Isotopes stock prices. Currently, shares of the company are trading approximately 70.3% above their 52-week average. Yet, despite this apparent market euphoria, the underlying financial metrics suggest a different narrative.
ASP Isotopes Inc. Surpasses Expectations with Early Completion of Ytterbium-176 Enrichment Facility, Shares Experience Minor Setback ASP Isotopes Inc. has recently reached a major milestone in advancing quantum enrichment technology with the completion of their state-of-the-art Ytterbium-176 enrichment facility. Despite initial projections forecasting completion within a year, the construction phase concluded nine months ahead of schedule, showcasing the company s commitment to innovation and efficient project management. The Ytterbium-176 enrichment plant marks a significant breakthrough in the field of quantum physics, allowing for the enhancement of isotopic purity and enabling scientists to harness the unique properties of Ytterbium-176. This rare and highly enriched isotope holds immense potential for various applications, including nuclear medicine, astrophysics, and quantum computing.
WASHINGTON, July 15, 2024 – ASP Isotopes Inc. (NASDAQ: ASPI), a leading player in the nuclear and critical resource industry, announced the successful completion of its underwritten public offering of common stock. This significant milestone marked not only the closure of the public offering but also the full exercise of the underwriters option to purchase additional shares. ASP Isotopes sold 13,800,000 shares of its common stock at a public offering price of $2.50 per share, resulting in total gross proceeds of $34.5 million, before deducting underwriting discounts, commissions, and offering expenses. The news comes on the heels of Tees River s monumental announcement on 9th October 2023, where the prominent uranium and critical resource investor unveiled its involvement in a groundbreaking pursuit for a revolutionary resource discovery. This development has sent shockwaves through the global investment landscape and has the potential to reshape various sectors, ranging from energy to technology and beyond.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
